Streetbeat News

Stock Prices

SPY

The USA Producer Price Index (PPI) for July came in at 2.2% year-over-year, slightly below the estimated 2.3% and down from the prior 2.7%.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:30 pm

SPY

The Producer Price Index (PPI) for July increased by 0.1%, which is below the estimated 0.2%.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:30 pm

SPY

The USA Core Producer Price Index (PPI) for July came in at 2.4% year-over-year, below the estimated 2.7% and the prior 3.0%.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:30 pm

GMAB

HBM

LUMN

ONON

TME

VSAT

WTO

On Holding AG (NYSE:ONON) reported mixed Q2 results, missing earnings estimates but beating revenue expectations. This led to an 8.6% drop in pre-market trading. Other stocks like Viasat, Inc. (NASDAQ:VSAT), UTime Limited (NASDAQ:WTO), Tencent Music Entertainment Group (NYSE:TME), Hudbay Minerals Inc. (NYSE:HBM), Genmab A/S (NASDAQ:GMAB), and Lumen Technologies, Inc. (NYSE:LUMN) also saw declines in pre-market trading.

Portfolio Pulse from Avi Kapoor

August 13, 2024 | 12:29 pm

NVDA

PAYC

PM

ZG

The article discusses notable insider sales for four companies: Philip Morris International, NVIDIA, Zillow, and Paycom Software. Insider sales can indicate various factors, including concerns about the company's prospects or the stock being overpriced. The article provides details on the sales and recent developments for each company.

Portfolio Pulse from Avi Kapoor

August 13, 2024 | 12:28 pm

PAVM

PAVmed (NASDAQ:PAVM) reported Q2 earnings per share (EPS) of $(1.19), beating the analyst estimate of $(1.45) by 17.93%. However, sales of $979K missed the $1.20M estimate by 18.42%. Despite the miss, sales increased by 489.76% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:28 pm

APVO

Aptevo Therapeutics has initiated a Phase 1b/2 RAINIER trial to evaluate its lead candidate Mipletamig (APVO436) in combination with Venetoclax and Azacitidine for frontline acute myeloid leukemia (AML). The new data from this trial is expected to bolster existing efficacy outcomes and identify the recommended Phase 2 dose.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:27 pm

DJT

Trump Media & Technology Group Corp. (NASDAQ:DJT) continues to decline in premarket trading after a significant drop on Monday. The company reported a Q2 loss of $16.4 million and revenue of $837,000. Trump's return to X and the faltering metrics of Truth Social are contributing to the stock's downward pressure.

Portfolio Pulse from Shanthi Rexaline

August 13, 2024 | 12:27 pm

SPRY

ARS Pharmaceuticals shares are trading higher after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $18 to $22.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:25 pm

EVOK

Evoke Pharma (NASDAQ:EVOK) reported Q2 earnings per share (EPS) of $(0.93), significantly missing the analyst estimate of $(0.06). The company also reported quarterly sales of $2.55 million, which fell short of the $2.98 million estimate. Despite the misses, sales increased by 125.58% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:23 pm